Common use of Diligence Report Clause in Contracts

Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreements diligence requirements. Each report will describe, where relevant: (i) progress by LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(S) toward commercialization of LICENSED PRODUCTS or LICENSED SERVICES, including work completed, key scientific discoveries, summary of work-in-progress, current schedule of anticipated events or milestones, market plans (if any) for introduction of LICENSED PRODUCTS or LICENSED SERVICES, and significant corporate transactions involving LICENSED PRODUCTS or LICENSED SERVICES; (ii) notice of all FDA or other governmental filings and/or approvals regarding any LICENSED PRODUCTS or LICENSED SERVICE made or obtained by LICENSEE, AFFILIATED COMPANY or SUBLICENSEE, the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; (iii) a Certificate of Insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not currently required; (iv) identification of all AFFILIATED COMPANIES and SUBLICENSEE(S) which have exercised rights to the LICENSED PATENTS, or a statement that no AFFILIATED COMPANY or SUBLICENSEE has exercised such rights; (v) description of any diligence milestones achieved, and identification of any milestones expected to be achieved in the next year; (vi) description of any sublicense(s) entered during the year, with a copy of the sublicense if not previously provided. (vii) Notification of any change of control, name change or other significant change related to this Agreement or LICENSEE. 4.3.2 Reports may be submitted electronically to an email address provided on request by JHU.

Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. Reports may be submitted electronically to an email address provided on request by JHU. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreements Agreement's diligence requirements. Each report will include LICENSEE's most recent annual report filed with the United States Securities and Exchange Commission, if applicable, and describe, where relevant: (i) progress by LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(S) toward commercialization of LICENSED PRODUCTS or LICENSED SERVICES, including work completed, key scientific discoveries, summary of work-in-progress, current schedule of anticipated events or milestones, market plans (if any) for introduction of LICENSED PRODUCTS or LICENSED SERVICES, and significant corporate transactions involving LICENSED PRODUCTS or LICENSED SERVICES; (ii) (notice of all FDA or other governmental filings and/or approvals regarding any LICENSED PRODUCTS or LICENSED SERVICE made or obtained by LICENSEE, AFFILIATED COMPANY or SUBLICENSEE, the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; (iii) a Certificate of Insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not currently required; (iv) identification of all AFFILIATED COMPANIES and SUBLICENSEE(S) which have exercised rights to the LICENSED PATENTSTECHNOLOGY, or a statement that no AFFILIATED COMPANY or SUBLICENSEE has exercised such rights; (v) description of any diligence milestones achieved, and identification of any milestones expected to be achieved in the next year; (vi) description of any sublicense(sSUBLICENSE(s) entered during the year, with a copy of the sublicense SUBLICENSE if not previously provided. (vii) Notification of any change of control, control or name change or other significant change related to this Agreement or LICENSEELICENSEE that would be relevant to the TECHNOLOGY licensed hereunder. 4.3.2 Reports may be submitted electronically to an email address provided on request by JHU.

Diligence Report. 4.3.1 By March 1 [**] of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT Exhibit C and shall include information reasonably sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreements Agreement’s diligence requirements. Each report will describe, where relevant: (i) progress by LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(S) toward commercialization of LICENSED PRODUCTS or LICENSED SERVICES, including work completed, key scientific discoveries, summary of work-in-progress, current schedule of anticipated events or milestones, market plans (if any) for introduction of LICENSED PRODUCTS or LICENSED SERVICES, and significant corporate transactions involving LICENSED PRODUCTS or LICENSED SERVICES; (ii) notice of all any FDA or other governmental filings and/or approvals regarding any LICENSED PRODUCTS or LICENSED SERVICE made or obtained by LICENSEE, AFFILIATED COMPANY or SUBLICENSEE, the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; (iii) a Certificate certificate of Insurance insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not currently required; (iv) identification of all AFFILIATED COMPANIES and SUBLICENSEE(S) which have exercised rights to the LICENSED PATENTSTECHNOLOGY, or a statement that no AFFILIATED COMPANY or SUBLICENSEE has exercised such rights; (v) description of any diligence milestones achievedachieved during the prior, and identification of any milestones expected to be achieved in the next year; (vi) description of any sublicense(s) sublicenses under the TECHNOLOGY that were entered during the year, with a copy of the sublicense agreement if not previously provided. (vii) Notification notification of any change of control, name change or other significant change related to this Agreement or LICENSEE. 4.3.2 Reports may be submitted electronically to an email address provided on request by JHU. Such reports shall be the Confidential Information of LICENSEE.

Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreements Agreement's diligence requirements. Each report will describe, where relevant: (i) progress by LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(S) toward commercialization of LICENSED PRODUCTS or LICENSED SERVICES, including work completed, key scientific discoveries, summary of work-in-in- progress, current schedule of anticipated events or milestones, market plans (if any) for introduction of LICENSED PRODUCTS or LICENSED SERVICES, and significant corporate transactions involving LICENSED PRODUCTS or LICENSED SERVICES; (ii) notice of all FDA or other governmental filings and/or approvals regarding any LICENSED PRODUCTS or LICENSED SERVICE made or obtained by LICENSEE, AFFILIATED COMPANY or SUBLICENSEE, the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; (iii) a Certificate of Insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not currently required; (iv) identification of all AFFILIATED COMPANIES and SUBLICENSEE(S) which have exercised rights to the LICENSED PATENTSTECHNOLOGY, or a statement that no AFFILIATED COMPANY or SUBLICENSEE has exercised such rights; (v) description of any diligence milestones achieved, and identification of any milestones expected to be achieved in the next year; (vi) description of any sublicense(sSUBLICENSE(s) entered during the year, with a copy of the sublicense SUBLICENSE if not previously provided. (vii) Notification of any change of control, name change or other significant change related to this Agreement or LICENSEE. 4.3.2 Reports may be submitted electronically to an email address provided on request by JHU.. 5 FEES, ROYALTIES AND OTHER PAYMENTS

Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreements Agreement’s diligence requirements. Each report will describe, where relevantre levant: (i) progress by LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(SorSUBLICENSEE(S) toward commercialization of LICENSED PRODUCTS or LICENSED SERVICES, including work completed, key scientific discoveries, summary of work-in-work -in- progress, current schedule of anticipated events or milestones, market plans (if any) for introduction of LICENSED PRODUCTS or LICENSED SERVICES, and significant corporate transactions involving LICENSED PRODUCTS or LICENSED SERVICES; (ii) notice of all FDA or other governmental filings and/or approvals regarding any LICENSED PRODUCTS or LICENSED SERVICE made or obtained by LICENSEE, AFFILIATED COMPANY or COMPANYor SUBLICENSEE, the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; (iii) a Certificate of Insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not currently required; (iv) identification of all AFFILIATED COMPANIES and SUBLICENSEE(S) which have exercised rights to the LICENSED PATENTSTECHNOLOGY, or a statement that no AFFILIATED COMPANY or COMPANYor SUBLICENSEE has exercised such rights; (v) description of any diligence milestones achieved, and identification of any milestones expected to be achieved in the next year; (vi) description of any sublicense(sSUBLICENSE(s) entered during the year, with a copy of the sublicense SUBLICENSE if not previously provided. (vii) Notification of any change of control, name change or other significant change related to this Agreement or LICENSEE. 4.3.2 Reports may be submitted electronically to an email address provided on request by JHU.. 5 FEES, ROYALTIES AND OTHER PAYMENTS

Diligence Report. 4.3.1 By March 1 of each year, LICENSEE will submit a written annual report to JHU covering the preceding calendar year. The report will follow the Diligence Report Guidelines stated on EXHIBIT C and shall include information sufficient to enable JHU to satisfy reporting requirements of the U.S. Government and for JHU to ascertain progress by LICENSEE toward meeting this Agreements Agreement's diligence requirements. Each report will describe, where relevant: (i) progress by LICENSEE, AFFILIATED COMPANIES or SUBLICENSEE(S) toward commercialization of LICENSED PRODUCTS or LICENSED SERVICES, including work completed, key scientific discoveries, summary of work-in-in- progress, current schedule of anticipated events or milestones, market plans (if any) for introduction of LICENSED PRODUCTS or LICENSED SERVICES, and significant corporate transactions involving LICENSED PRODUCTS or LICENSED SERVICES;or (ii) notice of all FDA or other governmental filings and/or approvals regarding any LICENSED PRODUCTS or LICENSED SERVICE made or obtained by LICENSEE, AFFILIATED COMPANY or SUBLICENSEE, the patents or patent applications licensed under this Agreement upon which such product or service is based, and the commercial name of such product or service; (iii) a Certificate of Insurance or other evidence of insurance, as required by this Agreement, or a statement of why such insurance is not currently required; (iv) identification of all AFFILIATED COMPANIES and SUBLICENSEE(S) which have exercised rights to the LICENSED PATENTSTECHNOLOGY, or a statement that no AFFILIATED COMPANY or SUBLICENSEE has exercised such rights; (v) description of any diligence milestones achieved, and identification of any milestones expected to be achieved in the next year; (vi) description of any sublicense(sSUBLICENSE(s) entered during the year, with a copy of the sublicense SUBLICENSE if not previously provided. (vii) Notification of any change of control, name change or other significant change related to this Agreement or LICENSEE. 4.3.2 Reports may be submitted electronically to an email address provided on request by JHU.